Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

Tanabe Pharma Corporation · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
alzheimersdiseasecognitivefunctiondementiamt
alzheimer's disease, mt-4666, α7 nicotinic acetylcholine receptor agonist, cognitive function, dementia, central nervous system agents, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 888430
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.